Skip to content
DataLookout
Menu

NCT07260578

Safety and Efficacy of Ellacor® Micro-coring® Following Best Practices on Technique and Post-Procedural Care

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 9 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from May 2026 to Mar 2027 Show 4 more changesShow less
    • Eligibility criteria expanded, about 8 words
    • Trial status changed: Enrolling by Invitation → Active, Not Recruiting
    • Study completion pushed from Jun 2026 to Apr 2027
    • Secondary endpoints: details revised at 1 of 1 entry
  2. Minor Trial status: Recruiting to Enrolling by Invitationv2 Show 4 more changesShow less
    • Primary completion date: Mar 2026 to May 2026
    • Study completion date: Mar 2026 to Jun 2026
    • Start date changed from estimate of Dec 2025 to Nov 26, 2025
    • Site details revised at 2 of 2 sites
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Global Aesthetic Improvement Scale (GAIS)
Timeframe: GAIS Assessment will be performed under a timeframe of 90 days

Secondary (1)

Clinical Assessment

Arms and interventions

Regenerating Skin Nectar (by Alastin) + TegadermActive comparator

Alastin to be applied post procedure followed up Tegaderm. Tegaderm will be left on for 12 hours. Alastin will be applied twice daily for the duration of the study

Kerra+ Recovery Cream (by Quthero) + TegadermActive comparator

Patients will receive Kerra+ post procedure followed by Tegaderm. The Tegaderm is removed after 12 hours. Kerra+ will be applied twice daily for the duration of the study.

Ariessence Platelet-Derived Growth Factor (PDGF) solution +Alastin + TegadermActive comparator

Patients will receive PDGF immediately post procedure followed by Alastin followed by Tegaderm. The Tegaderm will be removed after 12 hours and the Alastin will continue to be applied twice daily for the duration of the study

Ariessence PDGF solution + Kerra+ Recovery Cream + TegadermActive comparator

Patients will receive PDGF immediately post procedure followed by Kerra+ followed by Tegaderm. The Tegaderm will be removed after 12 hours and the Kerra+ will continue to be applied twice daily for the duration of the study

Tegaderm OnlyActive comparator

Patient will only receive Tegaderm for post-care

Devices: ellacor Micro-Coring Technology

Sites

2 sites in 1 country